Company profile: Alteris Therapeutics
1.1 - Company Overview
Company description
- Provider of discovery and development of therapeutics and vaccines, leveraging alternative splice forms and disease-specific splice variants to design truly disease-specific drugs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alteris Therapeutics
Osivax
HQ: France
Website
- Description: Provider of immunotherapy vaccines powered by the oligoDOM self-assembling nanoparticle platform to elicit potent T- and B-cell responses and enable universal vaccines against mutating pathogens. Pipeline includes OVX836, a universal influenza A vaccine targeting nucleoprotein; OVX033, a universal sarbecovirus vaccine targeting nucleocapsid; and PANHPVAX, a pan-strain HPV vaccine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osivax company profile →
Baliopharm
HQ: Germany
Website
- Description: Provider of novel therapeutics developing monoclonal and bispecific antibodies for autoimmune diseases, chronic liver diseases such as NASH, B-cell malignancies, and cancer. Products include Atrosab and Atrosimab, TNF-R1 targeting antibodies for liver and immune-mediated inflammatory diseases, and Novotarg, a CD20/CD95-targeting bispecific for autoimmune diseases and B-cell malignancies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baliopharm company profile →
Istari Oncology
HQ: United States
Website
- Description: Provider of novel immuno-oncology and immunotherapy platforms for glioblastoma, developing lerapolturev, an investigational immunotherapy based on the genetically modified Sabin type 1 polio vaccine targeting solid tumors, and running the LUMINOS studies: LUMINOS-101 (with pembrolizumab for recurrent glioblastoma), LUMINOS-102 (alone/with anti–PD-1 in metastatic melanoma), and LUMINOS-103 (basket study in solid tumors including bladder).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Istari Oncology company profile →
Arch Oncology
HQ: United States
Website
- Description: Provider of venture-stage biopharmaceutical solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arch Oncology company profile →
Dara Biosciences
HQ: United States
Website
- Description: Provider of oncology treatment and supportive care products, dedicated to commercialization as a specialty pharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dara Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alteris Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alteris Therapeutics
2.2 - Growth funds investing in similar companies to Alteris Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alteris Therapeutics
4.2 - Public trading comparable groups for Alteris Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →